SanMelix develops advanced homeopathic compositions efficient in the treatment of a variety of wound and dermal afflictions.
SanMelix develops advanced homeopathic compositions efficiently in the treatment of a variety of wound and dermal afflictions.The company develops its advanced wound healing therapeutics through understanding the natural mechanisms of action inherent in buckwheat honey, which produces improved clinical results. As a result of its research and development, SanMelix has patents pending for its unique therapeutic wound dressing compositions, BEECure products, which improve the efficacy of healing acute and chronic wounds.It was founded by Dr. Kenneth A. Sabacinski, Diana Sabacinski, CPA, and John Kaufman in Hollywood, Florida in 2016.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 1, 2020 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Newchip | — | Non-Equity Assistant |